announcement
high
2025-01-14
Announcement on the Release of the 'Compliance Guidelines for Pharmaceutical Enterprises on Preventing Commercial Bribery Risks'
市场监管总局关于发布《医药企业防范商业贿赂风险合规指引》的公告
市场监管总局
samr
This document announces the official release and implementation of the 'Compliance Guidelines for Pharmaceutical Enterprises on Preventing Commercial Bribery Risks', which was adopted by the State Administration for Market Regulation.
Document Text
206 characters
市场监管总局关于发布《医药企业<br>
防范商业贿赂风险合规指引》的公告<br>
《医药企业防范商业贿赂风险合规指引》已经2024年12月30日市场监管总局第<br>
32次局务会议通过，现予公告，自发布之日起施行。<br>
附件：医药企业防范商业贿赂风险合规指引<br>
市场监管总局 <br>
2025年1月10日 <br>
附件下载<br>
附件：医药企业防范商业贿赂风险合规指引.pdf
Topics
compliance
pharmaceutical industry
anti-corruption
Metadata
| Publisher | 市场监管总局 |
| Site | samr |
| Date | 2025-01-14 |
| Category | major_policy |
| Policy Area | 市场监管/医药合规 |
| CMS Category | 总局文件 |
| Keywords | 日,公告,医药,发布,总局 |
Verification
References (1)
| unkn 医药企业 防范商业贿赂风险合规指引 | named |
Citation Network
Full network →